Crossmark

Glucocorticoids promote transition of ductal carcinoma in situ to invasive ductal carcinoma by inducing myoepithelial cell apoptosis

Crossref DOI link: https://doi.org/10.1186/s13058-018-0977-z

Published Online: 2018-07-04

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zubeldia-Plazaola, Arantzazu

Recalde-Percaz, Leire

Moragas, Núria

Alcaraz, Mireia

Chen, Xieng

Mancino, Mario

Fernández-Nogueira, Patricia

Prats de Puig, Miquel

Guzman, Flavia

Noguera-Castells, Aleix

López-Plana, Anna

Enreig, Estel

Carbó, Neus

Almendro, Vanessa

Gascón, Pedro

Bragado, Paloma

Fuster, Gemma https://orcid.org/0000-0002-4501-2422
Funding

Funding for this research was provided by:

Instituto de Salud Carlos III (ISCIII) (PI08022)

Instituto de Salud Carlos III (PI15/00661)

RedesTemáticas de Investigación en Cáncer (RD12/00360055)

Eusko Jaurlaritza (ES) (BFI- 2011-59)

Secretaría de Estado de Investigación, Desarrollo e Innovación (JCI-2011-10799)
License Information

Text and Data Mining valid from 2018-07-04
More Information

Article History

Received: 22 December 2017

Accepted: 6 May 2018

First Online: 4 July 2018

Ethics approval and consent to participate

: Samples from patients with DCIS or DCIS+IDC were obtained from the Biobank of Hospital Clinic of Barcelona, IDIBAPS, after provision of informed consent and Institutional Ethics Committee approval.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.